anmelden
OMX Nordic 40
2.685,57
PKT
-21,68
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.05.19 | AstraZeneca overweight | Barclays Capital | |
| 21.05.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 17.05.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 17.05.19 | A.P. Moeller - Maersk A-S (B) kaufen | Credit Suisse Group | |
| 17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 14.05.19 | Volvo (B) Underperform | Merrill Lynch & Co., Inc. | |
| 14.05.19 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 13.05.19 | AstraZeneca Sell | UBS AG | |
| 13.05.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 10.05.19 | AstraZeneca buy | Deutsche Bank AG | |
| 10.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 07.05.19 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 07.05.19 | AstraZeneca Sell | UBS AG | |
| 07.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.05.19 | Novo Nordisk Neutral | Oddo BHF | |
| 07.05.19 | Novo Nordisk Reduce | HSBC | |
| 06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.05.19 | Nokia overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 03.05.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.05.19 | Novo Nordisk buy | UBS AG | |
| 02.05.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 01.05.19 | Nokia Sell | Goldman Sachs Group Inc. | |
| 30.04.19 | Nokia buy | Deutsche Bank AG | |
| 30.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 29.04.19 | Nokia overweight | Barclays Capital | |
| 26.04.19 | Nokia buy | Kepler Cheuvreux | |
| 26.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.04.19 | Nokia Outperform | Credit Suisse Group | |
| 26.04.19 | AstraZeneca Sell | UBS AG | |
| 26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 26.04.19 | Volvo (B) Neutral | JP Morgan Chase & Co. |
